Evolus (EOLS) Receivables (2019 - 2026)
Evolus (EOLS) reported Receivables of $52.2 million for Q1 2026, up 10.04% on a YoY basis from $47.5 million in Q1 2025, and down 4.53% quarter-over-quarter from $54.7 million in Q4 2025.
Evolus (EOLS) Receivables (2019 - 2026) Analysis & Trends
Evolus has reported Receivables for 8 years, with the latest figure at $52.2 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables rose 10.04% year-over-year to $52.2 million; the trailing twelve-month figure through Mar 2026 stood at $52.2 million (up 10.04% YoY), and the FY2025 full-year result was $54.7 million, up 14.71% from the prior year.
- Receivables for Q1 2026 stood at $52.2 million, down from $54.7 million in the prior quarter.
- The five-year high for Receivables was $54.7 million in Q4 2025, with the low at $16.8 million in Q1 2022.
- Historically, Receivables has averaged $36.3 million across 5 years, with a median of $34.2 million in 2024.
- The largest YoY upside for Receivables was 77.23% in 2022 against a maximum downside of 34.12% in 2022.
- Evolus' Receivables stood at $22.4 million in 2022, then surged by 36.0% to $30.5 million in 2023, then soared by 56.19% to $47.7 million in 2024, then advanced by 14.71% to $54.7 million in 2025, then fell by 4.53% to $52.2 million in 2026.
- The last three Receivables figures came in at $52.2 million (Q1 2026), $54.7 million (Q4 2025), and $50.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.39 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.51 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 312.00 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 31.29 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 768.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.15 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 407.63 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 355.67 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 149.62 Mn |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn | 52.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.22 Mn |
| Dec 31, 2025 | 54.70 Mn |
| Sep 30, 2025 | 50.44 Mn |
| Jun 30, 2025 | 47.71 Mn |
| Mar 31, 2025 | 47.45 Mn |
| Dec 31, 2024 | 47.68 Mn |
| Sep 30, 2024 | 44.64 Mn |
| Jun 30, 2024 | 43.15 Mn |
| Mar 31, 2024 | 34.24 Mn |
| Dec 31, 2023 | 30.53 Mn |
| Sep 30, 2023 | 30.46 Mn |
| Jun 30, 2023 | 29.00 Mn |
| Mar 31, 2023 | 23.46 Mn |
| Dec 31, 2022 | 22.45 Mn |
| Sep 30, 2022 | 20.92 Mn |
| Jun 30, 2022 | 21.03 Mn |
| Mar 31, 2022 | 16.80 Mn |
| Dec 31, 2021 | 14.66 Mn |
| Sep 30, 2021 | 13.29 Mn |
| Jun 30, 2021 | 11.86 Mn |